Table 1_Subjective spatial orientation discomfort is associated with decreased real-world spatial performance and lower cognitive function.docx by Johannes Gerb (10287758)

Screening for gHgLgO interaction partners reveals decreased binding of the gO249 mutant to cell surfaces. by Lena Thiessen (17605194)

Decreased expression of <i>catp-3</i> underlies compromised tolerance to oxidative stress in <i>shk-1</i> mutants. by Longjun Pu (20685717)

Effect of 1.25% SCFP on poultry cecal microbial composition inoculated with six multidrug-resistant (<i>MDR</i>) <i>Salmonella</i> serovars compared to a no-treatment control at 24... by Elena G. Olson (10649705)

Subjects:

Data from: <b>Selection and genetic variation in plasticity drive age-related decreases in among-individual behavioural correlations</b> by Chang Seok Han (21814121)

“…Our findings indicate that the magnitudes of both the positive among-individual and genetic correlations were maintained across nymph and young adult stages, but significantly decreased with age during adulthood. This decrease was due to both selection and genetic variation in age-related behavioural plasticity. …”

The Vancouver Scar Scale. by Na Wang (193263)

Subjects:

S1 Dataset - by Na Wang (193263)

Subjects:

Numerical Rating Scale (NRS). by Na Wang (193263)

Subjects:

Mammary fistula (n(%)). by Na Wang (193263)

Subjects:

Forest maps affecting lactation outcomes. by Na Wang (193263)

Subjects:

Postoperative drainage(ml) (M(IQR)). by Na Wang (193263)

Subjects:

Effect of Oxamate, LBP, or their combination on partial glycolysis metabolites in A549 and NCL-H1975 cells after 24 hours of treatment. by Siyu Yuan (7425719)

Subjects:

Changes in the growth of two oat varieties under drought stress and normal water supply treatments. by Caijin Chen (3107787)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

EF-24 treatment disrupts key molecular pathways associated with cell survival, proliferation, and viability. by Ajeet P. Singh (22298432)

Subjects:

Fig 10 - by Farshid Maleki (20521649)

Subjects:

Fig 4 - by Farshid Maleki (20521649)

Subjects:

Fig 9 - by Farshid Maleki (20521649)

Subjects:

Fig 6 - by Farshid Maleki (20521649)

Subjects: